{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-24-000143","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.066322+00:00","generated_at":"2026-05-30T01:58:29.479419+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Surgery Partners Q3 revenue $770.4M (+14.3% YoY); adjusted EBITDA $128.6M (+21.9%)","bullets":["Revenue $770.4M, +14.3% YoY; same-facility revenue +4.2% on 3.7% case growth.","Adjusted EBITDA $128.6M, +21.9% YoY; margin 16.7%, expanding 100 bps.","Net loss attributable to Surgery Partners was $31.7M.","FY 2024 outlook reaffirmed: revenue >$3.075B, adjusted EBITDA >$508M.","Cash $221.8M, revolver capacity $595.8M; total net debt/EBITDA 3.8x."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-24-000143","json":"https://secwatch.observer/filing/0001638833-24-000143.json","markdown":"https://secwatch.observer/filing/0001638833-24-000143.md","text":"https://secwatch.observer/filing/0001638833-24-000143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883324000143/0001638833-24-000143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883324000143/sgry-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:58:29.479419+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}